AXichem AB Valuation
| AXIC-A Stock | SEK 1.32 0.10 8.20% |
Today, the firm appears to be overvalued. aXichem AB shows a prevailing Real Value of kr1.17 per share. The current price of the firm is kr1.32. Our model approximates the value of aXichem AB from analyzing the firm fundamentals such as Current Valuation of 224.35 M, return on equity of -0.36, and Shares Outstanding of 16.54 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AXichem AB's price fluctuation is abnormally volatile at this time. Calculation of the real value of aXichem AB is based on 3 months time horizon. Increasing AXichem AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AXichem AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AXichem Stock. However, AXichem AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.32 | Real 1.17 | Hype 1.32 |
The real value of AXichem Stock, also known as its intrinsic value, is the underlying worth of aXichem AB Company, which is reflected in its stock price. It is based on AXichem AB's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AXichem AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of aXichem AB helps investors to forecast how AXichem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AXichem AB more accurately as focusing exclusively on AXichem AB's fundamentals will not take into account other important factors: AXichem AB Total Value Analysis
aXichem AB is presently forecasted to have takeover price of 224.35 M with market capitalization of 221.58 M, debt of 164 K, and cash on hands of 39.34 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AXichem AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
224.35 M | 221.58 M | 164 K | 39.34 M |
AXichem AB Investor Information
About 33.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.94. aXichem AB had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from AXichem AB's historical financial statements, aXichem AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.AXichem AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AXichem AB has an asset utilization ratio of 7.42 percent. This suggests that the Company is making kr0.0742 for each dollar of assets. An increasing asset utilization means that aXichem AB is more efficient with each dollar of assets it utilizes for everyday operations.AXichem AB Ownership Allocation
AXichem AB holds a total of 16.54 Million outstanding shares. aXichem AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.AXichem AB Profitability Analysis
The company reported the revenue of 4.36 M. Net Loss for the year was (15.09 M) with profit before overhead, payroll, taxes, and interest of 909 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AXichem AB's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AXichem AB and how it compares across the competition.
About AXichem AB Valuation
The stock valuation mechanism determines AXichem AB's current worth on a weekly basis. Our valuation model uses a comparative analysis of AXichem AB. We calculate exposure to AXichem AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AXichem AB's related companies.aXichem AB develops, patents, and markets natural-analogue industrial compounds for the marine, pest control, feed ingredient, and medical application markets in Sweden and internationally. It offers aXiphen-repellent, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables aXiphen-feed ingredient for pig and poultry diets and aXiphen for use in various foods and dietary supplements, as well as in the pharmaceutical industry. aXichem AB is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct AXichem AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AXichem AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AXichem AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AXichem AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AXichem AB's revenue streams: Identify AXichem AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AXichem AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AXichem AB's growth potential: Evaluate AXichem AB's management, business model, and growth potential.
- Determine AXichem AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AXichem AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for AXichem Stock analysis
When running AXichem AB's price analysis, check to measure AXichem AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AXichem AB is operating at the current time. Most of AXichem AB's value examination focuses on studying past and present price action to predict the probability of AXichem AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AXichem AB's price. Additionally, you may evaluate how the addition of AXichem AB to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |